Abiopharma

🔍 Conner Penelope M (Executive)

Company: EVERSOURCE ENERGY (ES)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 1,500 shares of Common Shares, $5.00 par value at $71.1 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,056.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,500 shares of Common Shares, $5.00 par value at $71.5 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,556.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Shares, $5.00 par value (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: By 401k Plan Trustee | shares_owned_after: 1,226.00 | Footnotes: F2
• Holds 17,511 shares of Phantom Shares (Derivative)
  Date: 2026-08-24 | Code: H | shares_owned_after: 17,511.00 | Footnotes: F3, F3, F3, F3, F3

Footnotes:

• F1: Includes restricted share units and dividend equivalents thereon.
• F2: Shares held in trust under the Eversource 401k Plan, a qualified plan, according to information supplied by the Plan's record keeper.
• F3: Reporting Person's deferred compensation under the Eversource Deferred Compensation Plan, a non-qualified plan, that is nominally invested as common shares. Each phantom share represents the right to receive one common share upon a distribution event, following vesting. Additional phantom shares are issued upon the automatic reinvestment of dividend-equivalents and are exempt from the line item reporting under SEC rule 16a-11.